School of Medicine
Showing 21-30 of 62 Results
-
Benedikt Geier
Postdoctoral Scholar, Infectious Diseases
BioB.Sc. Biology, Ludwig Maximilian University (LMU), Munich/Germany (2013)
M.Sc. Biology and bioimaging, Ludwig Maximilian University (LMU), Munich/Germany (2015)
Ph.D., Animal-Microbe Symbioses, Max Planck Institute for Marine Microbiology in Bremen/Germany (2020)
Benedikt joined the Amieva Lab from Germany in 2022. During his B.Sc. and M.Sc. programs in zoology, he became fascinated with 3D imaging approaches to study small animal microanatomy. He spent his PhD developing in situ imaging approaches to study deep-sea symbioses and fell in love with studying host-microbe interactions. In the Amieva Lab, Benedikt will advance his previously developed correlative chemical imaging techniques to resolve metabolic and cellular interactions that drive H. pylori pathogenesis in the gastric glands.
More about Benedikt's transition from deep-sea microbiology into infectious disease research can be found here:
https://scopeblog.stanford.edu/2022/08/24/unconventional-paths-deep-sea-to-the-stomach/ -
Elias Roth Gerrick
Member, Maternal & Child Health Research Institute (MCHRI)
BioEli received his B.S. in Microbiology and Immunology from U.C. Irvine in 2013, where he worked in the lab of Dr. Celia Goulding. He earned his Ph.D. from Harvard University in 2018 in the lab of Dr. Sarah Fortune, where he studied post-transcriptional regulation of gene expression in Mycobacterium tuberculosis. Eli joined the Howitt lab at Stanford in the summer of 2018, where he is studying the influence of protozoan members of the microbiome on intestinal immunity.
-
Ishita Ghai
Postdoctoral Scholar, General Internal Medicine
BioIshita Ghai is a health policy researcher that applies causal inference methods to understand how health behaviors are shaped through individual and group factors in low-resource settings. She mainly studies these empirical questions in the context of randomized controlled trials, or through evaluations leveraging exogenous shocks using quasi-experimental techniques. She has managed several pilot and large randomized controlled trials across sub-Saharan Africa studying the short and long-term effects of health interventions on health outcomes for women, children, and people living with HIV/AIDS. At Stanford, she will advance work on medicine policy specifically focused on the effects of the shingles vaccine on dementia risk among older populations.
She completed her doctoral studies in policy analysis (economics concentration) at the RAND School of Public Policy, and holds an MBA from the University of California, Davis, an Ed.M. in international education policy from Harvard University, and a B.Tech in bioinformatics from VIT University. -
Marc Ghanem
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsMarc's research focuses on leveraging deep learning to identify clinically relevant patterns within large medical datasets, aiming to deliver personalized and predictive healthcare solutions. Current projects include building comprehensive perioperative foundation model, optimizing neonatal total parenteral nutrition (TPN), analyzing anesthesiology research trends, and identifying differential responders and their characteristics in clinical trials.
-
Ruth Margaret Gibson
Visiting Scholar, Medicine - Primary Care and Population Health
BioDr. Ruth Gibson, PhD, is the founding Executive Director of the Stanford Geopolitical Human Impact Research Lab (Stanford Nenya). The lab examines how war, blockades, and sanctions affect human health, with particular attention to children. She is a visiting scholar at Stanford’s Center for Innovation in Global Health (CIGH) and an affiliated scholar at the Center for International Security and Cooperation (CISAC). She is co-leading the Lancet Series on Foreign Policy and Global Health in an Era of Geopolitical Crisis with Professor Gary Darmstadt. Through the Consortium of Universities for Global Health (CUGH) and Stanford’s CIGH, she convenes international panels on the health consequences of geopolitical crises. Before her academic career, Dr. Gibson spent a decade working in humanitarian and global health programs across eight countries on five continents, including active conflict zones. She is fluent in English and proficient in Mandarin Chinese (如詩 吉布森), French, and Spanish. She holds a PhD from the University of British Columbia, postdoctoral training from Stanford University, and an Honors Bachelor of Science and Master of Science from the University of Toronto. Her research has been published in The Lancet and The Lancet Global Health. Her work and commentary have been featured in The New York Times, The New Yorker, and TIME. She is available to journalists and media outlets seeking expert analysis on war, peace, and human health.
Contact: rmgibson@stanford.edu
Lab website: www.stanfordnenya.com -
Joshua Gillard
Postdoctoral Scholar, Cardiovascular Medicine
BioDr. Josh Gillard is a Canadian biomedical data scientist with experience in bioinformatics, machine learning, and immunology. After completing a BSc and a MSc in Experimental Medicine at McGill university, he relocated to the Netherlands for his PhD in bioinformatics at Radboud University in Nijmegen. During his PhD, he gained experience analyzing and interpreting complex immunological data (bulk and single-cell transcriptomics, high-dimensional cytometry, high-throughput proteomics) derived from human observational or intervention studies (vaccination and experimental human infection). This work revealed molecular and cellular correlates of clinically important endpoints such as disease severity, symptom progression, and antibody responses. In 2022, Josh relocated to Stanford to join the Gaudilliere lab to develop and apply multi-omic data integration and machine learning techniques, establishing that early gestational immune dysregulation can predict preterm birth. Since 2024, in the Ashley lab, Josh is developing deep learning models to investigate aberrant splicing in cardiovascular disease.